US-based Concentrics Research and STATKING Clinical Services have formed a joint venture (JV) to provide contract research organisation (CRO) services.
The CRO services provided under the strategic partnership also include data management and statistical services.
Concentrics president and CEO Julie Aker said: “This formalises a partnership that has existed for many years, it extends Concentrics’ in-house services for clinical data management and statistical services.
“We are delighted to expand our process integration and consultative services since our research studies have all become more challenging and complex. STATKING offers comprehensive statistical design, programming and analysis capabilities to complement Concentrics’ CRO services.”
Concentrics is a provider of CRO services for late-stage studies, including research design and execution expertise for pharmaceutical and medical device firms.
Other services provided include protocol development, recruitment, IRB submission, data collection, monitoring, and medical writing.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below formBy GlobalData
Concentrics employs staff with expertise in research, quality, information technology (IT), medical, and telemedicine services.
STATKING president and CEO Dennis King said: “This JV incorporates Concentrics’ infrastructure for quality assurance and information technology into STATKING’s services to facilitate regulatory compliance and audit readiness.
“We are proud of our accomplishment to formalise this partnership.”
STATKING Clinical Services is a provider of clinical data management for clinical trials in order to receive the regulatory approval of new drugs and medical device products.